governmentEvidence level AIndependent

Evidence page

Same Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers Regarding the Scope of the Exception – Guidance for Industry

U.S. Food and Drug Administration

accessed Nov 10, 2026Updated Nov 10, 2026

Original source

https://www.fda.gov/media/89920/download

fda.gov

Verification

Verification	Independent of the subject
Evidence level	A · Government / regulator
Independent	Independent of the subject
Source	government
Link status	Reachable at last check

Official claims are statements by the provider; they are not verified by worldwiki unless marked otherwise. Source policy

Cited by (2)

FactAutologous Fat Grafting: US regulatory status (FDA) = Fat removed and reimplanted in the same person during the same surgical procedure may qualify for the 21 CFR 1271.15(b) exception if processing is limited to rinsing, cleansing, sizing and shaping (FDA final guidance, November 2017)FactAutologous Fat Grafting: Processed adipose cell products (US) = The FDA considers processing that isolates cellular components from fat, such as enzymatic digestion, to go beyond the same surgical procedure exception